Publication | Open Access

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Metastatic Squamous-cell CarcinomaOpen-label Phase 3MedicinePathologyHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer ResearchMolecular Oncology